Medical Technologies

Medical devices, digital health, medical artificial intelligence, surgical robots, and diagnostic technologies.

107 Articles

Turkish Project Develops Portable Diagnosis for Vertigo and Balance Disorders

Specialists from Kocaeli and Kahramanmaraş are developing two portable systems to analyze eye and head movements using a mobile phone or laptop, with the aim of facilitating examinations for vertigo and balance disorders outside specialized balance laboratories. The projects are still in the clinical study phase.

2026-08-19

Medical Technologies

A Startup Believes AI’s Problem in Drug Discovery Is the Lack of Human Tissue Data

Vivodyne says that the AI models used in drug discovery lack causal data derived from living human tissues, and is betting on robotic laboratories to produce it. The company presents its vision as a solution to a problem beyond the capabilities of current models, not as evidence that a cancer cure is near.

2026-08-19

Medical Technologies

Five Questions About Abbott’s Glucose and Ketone Monitoring Sensor

Abbott is preparing to launch Libre Duo, a sensor that combines glucose and ketone measurement, after receiving the CE mark and submitting an application to the FDA. The device raises practical questions about eligible populations, interpreting readings, educating users, cost, and the limits of relying on ketones alone.

2026-08-19

Medical Technologies

U.S. Food and Drug Administration Authorizes Aletta Robotic Blood-Draw Device Without Direct Manual Intervention

The FDA has authorized Vitestro’s Aletta device, the first autonomous robotic device of its kind to draw blood from a patient’s arm without direct manual intervention during the procedure. Its use is currently limited to adults in outpatient clinics, with every session remaining under the supervision of a professional trained in blood collection.

2026-08-19

Medical Technologies

Trump Nominates Heidi Overton to Lead the U.S. Food and Drug Administration

U.S. President Donald Trump nominated Heidi Overton, a senior White House aide and physician specializing in public health and preventive medicine, to serve as commissioner of the Food and Drug Administration. The nomination requires Senate approval, while the pharmaceutical sector is watching how her limited political experience in drug regulation may affect the agency’s work.

2026-08-19

Medical Technologies

Guardant Health Bets on Blood Tests to Expand Early Cancer Detection

Guardant Health is seeking to expand use of the Shield test for colorectal cancer detection while developing a new generation designed to improve its ability to detect early-stage disease and precancerous lesions. The company is also working on a multicancer test covering 10 types, but it still needs to gather additional evidence before seeking FDA approval.

2026-08-18

Medical Technologies

U.S. Food and Drug Administration Selects Three Participants in Digital Health Device Pilot Program

The FDA selected three manufacturers to participate in the TEMPO pilot program, which aims to expand access to digital health devices intended to improve outcomes for patients with chronic diseases under the ACCESS model. The companies will collect real-world use data, while the FDA has not yet evaluated the effectiveness of the devices for the specific uses covered by the program.

2026-08-16

Medical Technologies

VIDRAFT Launches an Open Challenge to Evaluate AI-Designed Malaria Drug Molecules

VIDRAFT has announced the opening of the first season of the Open Discovery Challenge, a public leaderboard that evaluates AI-designed malaria drug candidates using metrics including intracellular activity, target binding, selectivity, toxicity, and manufacturability. The malaria season runs until September 30, 2026, and the leader receives a $1,000 prize.

2026-08-15

Medical Technologies

AMS shareholders approve sale of the company to H.B. Fuller for £715 million

H.B. Fuller received approval from Advanced Medical Solutions Group shareholders for the acquisition deal, which is expected to be completed before the end of 2026. The deal will expand H.B. Fuller’s presence in surgical biomaterials, adhesives and medical mechanical closures.

2026-08-14

Medical Technologies

Healthcare AI Alliance Forms Working Group to Address Risks of Advanced AI Models

The Coalition for Health AI formed a working group comprising approximately 100 leaders from healthcare systems, insurance companies, and the technology sector, with the goal of developing cybersecurity guidance and tools related to advanced AI models before the end of 2026. The group will focus on helping healthcare organizations defend against attacks and use these models safely.

2026-08-14

Medical Technologies

Senseonics Completes Transfer of Eversense 365 Sales to Internal Management and Plans Fully Implantable Sensor

Senseonics has completed the transfer of marketing and sales operations for the Eversense 365 continuous glucose monitor from Ascensia Diabetes Care to its internal teams in the United States and Europe, coinciding with record revenue of $14.5 million in the second quarter. The company is developing a fully implantable version of the sensor capable of communicating directly with a phone for one year.

2026-08-13

Medical Technologies

Google unveils Pixel Watch 5 with Gemini assistant and advanced health tracking

Google announced the Pixel Watch 5, combining a proactive Gemini assistant with improvements to GPS tracking and Health Guardian features for monitoring health indicators and monthly trends. Preorders begin on August 12, and the device will go on sale on August 20 at a starting price of $399.

2026-08-12

Medical Technologies

Orthopedic Companies Do Not Expect Implant Prices to Decline Despite Medicare Changes

Stryker and Zimmer Biomet believe the new Medicare model for joint replacement surgeries will not put much pressure on implant prices, while an analyst warns that medical device companies may have to demonstrate the technological impact of their products in reducing readmissions and emergency visits.

2026-08-11

Medical Technologies

Medical Device Companies Support MDUFA VI Agreement, While Patients Call for Stronger Post-Market Safety

The latest agreement to fund medical device fees in the United States enjoys broad industry support, but patient groups are calling for expanded use of real-world evidence to monitor devices after they reach the market. The agreement includes higher fees for foreign companies, greater transparency regarding staffing at the medical device division, and the conversion of the TAP program into a permanent program.

2026-08-10

Medical Technologies

When Is Building Software Better Than Buying It? NYU Langone and Dana-Farber’s Experience Supporting Cancer Treatment Decisions

NYU Langone Health and Dana-Farber Cancer Institute developed the Solavia Decision Suite to help oncologists connect patient data with research, guidelines, and treatments within the electronic health record. After testing it internally, the platform became commercially available to other health systems in an experience that highlights the criteria for choosing between building and buying software.

2026-08-10

Medical Technologies

FDA Sets Design and Marketing Considerations for Over-the-Counter Medical Devices

The U.S. Food and Drug Administration (FDA) explains the regulatory and design standards that manufacturers of over-the-counter medical devices should consider, from usability and labeling to clinical evidence and connected software. It also explains when a new 510(k), De Novo request, or PMA application may be required when converting a device from prescription use to direct-to-consumer use.

2026-08-02

Medical Technologies

Six Trends That Reshaped the Landscape of Medical Innovation in 2025

IEEE Spectrum’s review of the most prominent biomedical stories of 2025 highlights a mix of artificial intelligence applications and older technologies repurposed for new uses, from brain implants and graphene tattoos to Wi-Fi heart monitoring and robotic surgery. These examples reveal promising opportunities, but they remain at varying research or experimental stages and face challenges related to accuracy, safety, and privacy.

2025-12-21